NCT06290544 Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)
| NCT ID | NCT06290544 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centro Cardiologico Monzino |
| Condition | Diabetes Mellitus, Type 1 |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-11-29 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2021-11-29 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multicenter prospective collection of data with diagnostic procedures different from standard clinical care in a specific cohort of patients, aimed to evaluate cardiovascular risk stratification with the European Society of Cardiology (ESC)/European Association for the Study of Diabetes (EASD) guidelines and "The Steno Type 1 Risk Engine" algorithm. The correlation between CVD risk, atherosclerosis, and microvascular complications of diabetes (retinopathy, nephropathy, and neuropathy) will then be evaluated, and the impact of glycemic variability and other glucose metrics on vascular damage will be characterized. The investigators plan to enroll at least 200 consecutive type 1 diabetes mellitus (T1DM) patients who meet all the inclusion criteria and none of exclusion criteria.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of type 1 diabetes mellitus. * Age ≥ 18 years. * Signed Informed consent Exclusion Criteria: * Age \< 18 years. * Pregnancy in progress. * Type 2 diabetes mellitus. * Secondary diabetes
Contact & Investigator
Stefano Genovese, MD
PRINCIPAL INVESTIGATOR
IRCCS Centro Cardiologico Monzino
Frequently Asked Questions
Who can join the NCT06290544 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus, Type 1. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06290544 currently recruiting?
Yes, NCT06290544 is actively recruiting participants. Contact the research team at stefano.genovese@cardiologicomonzino.it for enrollment information.
Where is the NCT06290544 trial being conducted?
This trial is being conducted at Milan, Italy, Monza, Italy.
Who is sponsoring the NCT06290544 clinical trial?
NCT06290544 is sponsored by Centro Cardiologico Monzino. The principal investigator is Stefano Genovese, MD at IRCCS Centro Cardiologico Monzino. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.